19-4816148-A-C

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_182919.4(TICAM1):​c.*91T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.253 in 1,388,318 control chromosomes in the GnomAD database, including 45,987 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.27 ( 5701 hom., cov: 32)
Exomes 𝑓: 0.25 ( 40286 hom. )

Consequence

TICAM1
NM_182919.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.648
Variant links:
Genes affected
TICAM1 (HGNC:18348): (TIR domain containing adaptor molecule 1) This gene encodes an adaptor protein containing a Toll/interleukin-1 receptor (TIR) homology domain, which is an intracellular signaling domain that mediates protein-protein interactions between the Toll-like receptors (TLRs) and signal-transduction components. This protein is involved in native immunity against invading pathogens. It specifically interacts with toll-like receptor 3, but not with other TLRs, and this association mediates dsRNA induction of interferon-beta through activation of nuclear factor kappa-B, during an antiviral immune response. Mutations in this gene are associated with encephalopathy, acute, infection-induced. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 19-4816148-A-C is Benign according to our data. Variant chr19-4816148-A-C is described in ClinVar as [Benign]. Clinvar id is 2688085.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.409 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TICAM1NM_182919.4 linkuse as main transcriptc.*91T>G 3_prime_UTR_variant 2/2 ENST00000248244.6
TICAM1NM_001385678.1 linkuse as main transcriptc.*91T>G 3_prime_UTR_variant 3/3
TICAM1NM_001385679.1 linkuse as main transcriptc.*91T>G 3_prime_UTR_variant 2/2
TICAM1NM_001385680.1 linkuse as main transcriptc.*91T>G 3_prime_UTR_variant 3/3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TICAM1ENST00000248244.6 linkuse as main transcriptc.*91T>G 3_prime_UTR_variant 2/21 NM_182919.4 P1

Frequencies

GnomAD3 genomes
AF:
0.266
AC:
40463
AN:
151916
Hom.:
5693
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.249
Gnomad AMI
AF:
0.146
Gnomad AMR
AF:
0.301
Gnomad ASJ
AF:
0.238
Gnomad EAS
AF:
0.424
Gnomad SAS
AF:
0.270
Gnomad FIN
AF:
0.368
Gnomad MID
AF:
0.241
Gnomad NFE
AF:
0.244
Gnomad OTH
AF:
0.265
GnomAD4 exome
AF:
0.251
AC:
310519
AN:
1236284
Hom.:
40286
Cov.:
30
AF XY:
0.250
AC XY:
149533
AN XY:
597454
show subpopulations
Gnomad4 AFR exome
AF:
0.249
Gnomad4 AMR exome
AF:
0.344
Gnomad4 ASJ exome
AF:
0.246
Gnomad4 EAS exome
AF:
0.464
Gnomad4 SAS exome
AF:
0.252
Gnomad4 FIN exome
AF:
0.342
Gnomad4 NFE exome
AF:
0.239
Gnomad4 OTH exome
AF:
0.254
GnomAD4 genome
AF:
0.266
AC:
40505
AN:
152034
Hom.:
5701
Cov.:
32
AF XY:
0.273
AC XY:
20317
AN XY:
74306
show subpopulations
Gnomad4 AFR
AF:
0.250
Gnomad4 AMR
AF:
0.302
Gnomad4 ASJ
AF:
0.238
Gnomad4 EAS
AF:
0.424
Gnomad4 SAS
AF:
0.269
Gnomad4 FIN
AF:
0.368
Gnomad4 NFE
AF:
0.244
Gnomad4 OTH
AF:
0.262
Alfa
AF:
0.236
Hom.:
5528
Bravo
AF:
0.261
Asia WGS
AF:
0.333
AC:
1159
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 56% of patients studied by a panel of primary immunodeficiencies. Number of patients: 53. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.78
DANN
Benign
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs8120; hg19: chr19-4816160; API